PackGene Biotech provides CRO/CDMO services for gene therapy and cell therapy researchers and developers.
PackGene Biotech has raised $14.1M in total funding. The most recent round was Series C. The last funding was announced in December 2023.
PackGene Biotech's investors include HSG, Cathay Capital, Decheng Capital, Oriza Holdings, Oriza Seed Capital (Oriza Yuandian).
PackGene Biotech is headquartered in Houston, United States.
PackGene Biotech provides CRO/CDMO services for gene therapy and cell therapy researchers and developers.
PackGene Biotech is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PackGene Biotech — Funding & Investors." VCBacked, December 1, 2023, https://www.vcbacked.co/company/packgene-biotech. Accessed October 16, 2026.
VCBacked. (2023). PackGene Biotech — Funding & Investors. Retrieved October 16, 2026, from https://www.vcbacked.co/company/packgene-biotech
{{cite web |title=PackGene Biotech — Funding & Investors |url=https://www.vcbacked.co/company/packgene-biotech |website=VCBacked |access-date=October 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated